JPS6366538B2 - - Google Patents

Info

Publication number
JPS6366538B2
JPS6366538B2 JP6993979A JP6993979A JPS6366538B2 JP S6366538 B2 JPS6366538 B2 JP S6366538B2 JP 6993979 A JP6993979 A JP 6993979A JP 6993979 A JP6993979 A JP 6993979A JP S6366538 B2 JPS6366538 B2 JP S6366538B2
Authority
JP
Japan
Prior art keywords
capsule
liquid
soft capsules
capsules
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP6993979A
Other languages
Japanese (ja)
Other versions
JPS55163049A (en
Inventor
Kaoru Nemoto
Toshichika Ogasawara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP6993979A priority Critical patent/JPS55163049A/en
Publication of JPS55163049A publication Critical patent/JPS55163049A/en
Publication of JPS6366538B2 publication Critical patent/JPS6366538B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は軟カプセルの製法に関する。 従来軟カプセルの製法としては、液状のカプセ
ル化物質、例えばゼラチン液を環状孔から押出す
と同時に上記環状口の内側に同心円状に設けられ
た内孔口よりカプセル充填剤を押出し、この複合
ジエツトを冷却液中にて所望の粒径に造粒する、
いわゆる、例えば特公昭36−3700号公報に記載の
装置を用いた液中硬化被覆法によるシームレス軟
カプセル製造法が知られている。 この方法においてはカプセル造粒用冷却液とし
ては流動パラフインが常用されている。流動パラ
フインはその比重、粘度等の特性値が軟カプセル
の製造に好適に利用されているのであるが、反面
他溶媒との相溶性の悪さから、製造したカプセル
に付着した流動パラフインの洗滌にはトリクロロ
エタンの使用が余儀ない。トリクロロエタンの使
用が流動パラフインの洗滌に不可欠とはいうもの
の、その毒性は作業者にとつて好ましいものと言
い難いばかりでなく、本発明者らの研究によれ
ば、トリクロロエタンはゼラチン被膜を侵透し、
カプセル充填剤を汚染し、服用者に対する危険性
を有し又医薬品の安定性を害するものであること
が判明している。 本発明者らはこれらの点に鑑み鋭意研究の結
果、従来用いられてきた流動パラフインに替えて
次の一般式 (式中R1およびR2はアルキル基を、R3および
R4は水素原子または低級アルキル基を意味す
る。)で表わされる化合物を用いることにより極
めて安全で効率よく軟カプセルを製造し得ること
を見出し、更に検討を加えて本発明を完成した。 一般式()で表わされる化合物は公知物質で
化粧品製造原料として用いられる極めて低毒性の
常温で液体の物質である。 例えば一般式()におけるR1およびR2が1
―エチルペンチル基、R3およびR4がメチル基で
ある化合物(コスモール525なる商品名で市販さ
れている)は比重:約0.91、凝固点:−30℃以下
の無味・無臭の透明液体で25℃における粘度:10
〜13cpsという物理的性質を有する他、化学的に
も安定で酸・アルカリによる加水分解をほとんど
起すことなく空気中の酸素による影響も無視し得
る程度である。 このような化合物類を液中硬化被覆法による冷
却溶媒として用いることによりカプセルの造粒調
整が容易となり、従つて高速で製造されたカプセ
ルの重量偏差は驚くほど小さい。 更にカプセルの洗滌には危険なトリクロロエタ
ンを用いる必要がなく、低毒性のアルコール類で
簡単に処理でき、乾燥時間も極度に短縮すること
ができ、軟カプセルの量産に最適である。 また、このように優れた特性は、ロータリー式
軟カプセルの付着防止剤として全く同様に有利に
用いられ、同様の効果を上げることができ軟カプ
セルの製造に寄与するところ大である。 実施例 1 グローベツクス社(オランダ)製シームレス軟
カプセル製造機MarkによりビタミンD3のゼラ
チン被膜軟カプセルを次の処方により製造した。 <ゼラチン液処方> ゼラチン 100 部 グリセリン 30 〃 ソルビン酸カリウム 0.4〃 <充填物処方>(1カプセル中) VD3 1μg エタノール 0.8mg MCT 全量60mgとする <剤皮重量>40mg(1カプセル) 冷却溶媒として流動パラフインを用いた場合
(対照)と本発明(冷却溶媒として前記コスモー
ル525使用)の場合とを比較すると第1表のとお
りである。
The present invention relates to a method for manufacturing soft capsules. Conventionally, soft capsules are manufactured by extruding a liquid encapsulating material, such as a gelatin solution, through an annular hole, and at the same time extruding a capsule filler through an inner hole provided concentrically inside the annular opening. granulate to the desired particle size in a cooling liquid,
A so-called seamless soft capsule manufacturing method is known, for example, by a submerged curing coating method using an apparatus described in Japanese Patent Publication No. 36-3700. In this method, liquid paraffin is commonly used as the cooling liquid for capsule granulation. Liquid paraffin is suitable for use in the production of soft capsules due to its specific gravity, viscosity, and other properties, but on the other hand, due to its poor compatibility with other solvents, it is not suitable for cleaning liquid paraffin adhering to produced capsules. Trichloroethane must be used. Although the use of trichloroethane is indispensable for cleaning liquid paraffin, its toxicity is not only not favorable for workers, but also, according to research by the present inventors, trichloroethane can penetrate gelatin coatings. ,
It has been found that it contaminates capsule fillers, poses a risk to users, and impairs the stability of pharmaceutical products. In view of these points, the inventors of the present invention have conducted extensive research, and have developed the following general formula in place of the conventionally used liquid paraffin. (In the formula, R 1 and R 2 are alkyl groups, R 3 and
R 4 means a hydrogen atom or a lower alkyl group. ) It was discovered that soft capsules could be produced extremely safely and efficiently by using the compound represented by the following formula, and after further investigation, the present invention was completed. The compound represented by the general formula () is a known substance that is liquid at room temperature and has extremely low toxicity and is used as a raw material for manufacturing cosmetics. For example, R 1 and R 2 in the general formula () are 1
- A compound in which ethylpentyl group and R 3 and R 4 are methyl groups (commercially available under the trade name Cosmol 525) has a specific gravity of approximately 0.91 and a freezing point of -30°C or lower, a tasteless and odorless transparent liquid at 25°C. Viscosity at: 10
In addition to its physical properties of ~13 cps, it is also chemically stable, hardly being hydrolyzed by acids or alkalis, and the effect of oxygen in the air can be ignored. By using such compounds as a cooling solvent in the submerged curing coating method, it becomes easy to control the granulation of capsules, and therefore the weight deviation of capsules produced at high speed is surprisingly small. Furthermore, there is no need to use dangerous trichloroethane to wash the capsules, they can be easily treated with low-toxicity alcohols, and the drying time can be extremely shortened, making it ideal for mass production of soft capsules. Moreover, such excellent properties can be advantageously used as an anti-adhesion agent for rotary type soft capsules, and the same effect can be achieved, greatly contributing to the production of soft capsules. Example 1 Gelatin-coated soft capsules of vitamin D 3 were manufactured using a seamless soft capsule manufacturing machine Mark manufactured by Globex (Netherlands) according to the following formulation. <Gelatin liquid formulation> Gelatin 100 parts Glycerin 30〃 Potassium sorbate 0.4〃 <Filling formula> (in 1 capsule) VD 3 1μg Ethanol 0.8mg MCT Total amount 60mg <Coat weight> 40mg (1 capsule) As cooling solvent Table 1 shows a comparison between the case using liquid paraffin (control) and the case of the present invention (using Cosmol 525 as the cooling solvent).

【表】 表に示したように対照の重量偏差は4%以上と
大きく、これが本製法の大きな欠点でもある。又
カプセル破壊強度はバラツキが大きく商品価値上
大きな問題である。特に冷却液を流動パラフイン
で製したカプセルは流動パラフインの粘度が高い
ので圧力伝達が悪く、カプセルの一部に切り口が
残る。この切り口は必らずでき、その部分の被膜
の厚さは局部的に薄くなり、その結果カプセル破
壊強度は低下する。 一方、本発明の場合コスモール525は低粘度で
あるから圧力伝達も高くなりカプセルがシヤープ
に切れる。よつてカプセルの切り口は全く残らな
いのでカプセル破壊強度は高まり重量偏差も著し
く改善される。 更にトリクロロエタンの残留性を比較すると対
照は1カプセル当り40ppm以上混入し、その結果
主剤の安定性はきわめて悪くなる。 然し、本発明の場合安定性で問題となるトリク
ロロエタンは製造工程から完全に除去できるので
主剤の安定性は著しく安定化できる。 実施例 2 充填物処方を1カプセル中 リピドトロンボプラスチン 150mg MCT 210mg とし、剤皮重量160mg/1カプセルとした他は実
施例1と同様にし第2表の結果を得た。
[Table] As shown in the table, the weight deviation of the control was as large as 4% or more, which is also a major drawback of the present manufacturing method. Furthermore, the capsule breaking strength varies widely, which is a big problem in terms of commercial value. In particular, capsules made of liquid paraffin as a cooling liquid have poor pressure transmission due to the high viscosity of liquid paraffin, leaving a cut in a portion of the capsule. This cut inevitably occurs, and the thickness of the coating in that area becomes locally thinner, resulting in a decrease in capsule rupture strength. On the other hand, in the case of the present invention, since Cosmol 525 has a low viscosity, pressure transmission is also high and the capsule can be cut sharply. Therefore, no cut ends of the capsule remain, so the capsule breaking strength is increased and the weight deviation is significantly improved. Furthermore, when comparing the residual strength of trichloroethane, the control contained more than 40 ppm per capsule, and as a result, the stability of the main ingredient was extremely poor. However, in the case of the present invention, trichloroethane, which poses a stability problem, can be completely removed from the production process, so the stability of the main ingredient can be significantly stabilized. Example 2 The filling formulation was the same as in Example 1, except that 1 capsule contained 150 mg of lipidothromboplastin and 210 mg of MCT, and the shell weight was 160 mg/capsule, and the results shown in Table 2 were obtained.

【表】 上記の通り、ほぼ実施例1と同様に本発明の軟
カプセルが対照に較べて著しく優れていることが
示された。
[Table] As shown above, almost the same as in Example 1, the soft capsules of the present invention were shown to be significantly superior to the control.

Claims (1)

【特許請求の範囲】 1 一般式 (式中R1およびR2は同一又は異なつてもよい
アルキル基を、R3およびR4は水素原子または低
級アルキル基を意味する。) で表される化合物をシームレス軟カプセル製造の
際のカプセル形成用冷却液またはロータリー式軟
カプセル製造機のローターに設けられたカプセル
形成用凹部とカプセル形成物質との付着防止液と
して使用することを特徴とする軟カプセルの製
法。 2 R1およびR2が1―エチルペンチル基、R3
よびR4がメチル基である特許請求の範囲第1項
記載の方法。
[Claims] 1. General formula (In the formula, R 1 and R 2 are alkyl groups that may be the same or different, and R 3 and R 4 are hydrogen atoms or lower alkyl groups.) A method for producing soft capsules, which is used as a cooling liquid for forming or as a liquid for preventing adhesion between a capsule forming substance and a capsule forming recess provided in a rotor of a rotary type soft capsule manufacturing machine. 2. The method according to claim 1, wherein R 1 and R 2 are 1-ethylpentyl groups, and R 3 and R 4 are methyl groups.
JP6993979A 1979-06-06 1979-06-06 Preparation of soft capsule Granted JPS55163049A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6993979A JPS55163049A (en) 1979-06-06 1979-06-06 Preparation of soft capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6993979A JPS55163049A (en) 1979-06-06 1979-06-06 Preparation of soft capsule

Publications (2)

Publication Number Publication Date
JPS55163049A JPS55163049A (en) 1980-12-18
JPS6366538B2 true JPS6366538B2 (en) 1988-12-21

Family

ID=13417127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6993979A Granted JPS55163049A (en) 1979-06-06 1979-06-06 Preparation of soft capsule

Country Status (1)

Country Link
JP (1) JPS55163049A (en)

Also Published As

Publication number Publication date
JPS55163049A (en) 1980-12-18

Similar Documents

Publication Publication Date Title
US20200138723A1 (en) Hydroxypropyl methyl cellulose hard capsules and process of manufacture
JP5666595B2 (en) Aqueous composition for enteric hard capsule, method for producing enteric hard capsule, and enteric hard capsule
JP3822810B2 (en) Capsule sealing method
US6887307B1 (en) Pullulan film compositions
US7045184B2 (en) Polyvinyl alcohol compositions
WO2001091721A2 (en) Modified starch as a replacement for gelatin in soft gel films and capsules
WO2000018835A1 (en) Modified starch film compositions
WO2008119943A2 (en) Enteric pharmaceutical capsules
EP1942878A2 (en) Method for banding hard capsules using hydroxypropylmethyl cellulose (hpmc) as a base
JP2004526664A (en) Method of preparing a pharmaceutical composition for use with a soft gelatin formulation
JP2552937B2 (en) Pharmaceutical hard capsule and method for producing the same
JP4652052B2 (en) Film coating for tablets and caplets
EP1072633A1 (en) Pullulan film compositions
JP2013503847A (en) Flavored capsules
JP6227646B2 (en) Aqueous composition for producing hard capsule and method for producing the same, hard capsule, and method for reusing hard capsule scrap
JPS6366538B2 (en)
JPH0561943B2 (en)
US9700518B1 (en) Dip molding process for the manufacture of hard capsule shells
JP7377782B2 (en) Film forming composition and film
JPH07550B2 (en) Essential oil containing soft capsule
JP2014532069A (en) Injection molded dosage form
JP2007001873A (en) Coating composition and coated solid preparation
JP2002167444A (en) Rigid gelatin capsule having increased lubricity by decreasing static electricity of its coated film
JP2004315466A (en) Coating composition for capsule
JPS6336259B2 (en)